# Marchex Inc: overview MCHX · Nasdaq · CIK 1224133 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/mchx.md) · [Financials](/companies/mchx/financials.md) · [Filings](/companies/mchx/filings.md) · [Insiders](/companies/mchx/insiders.md) Latest reported revenue: [$11.0m](/filings/0001193125-26-349234.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-349234). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [12.6](/filings/0001193125-25-282989.md) | [11.9 d](/filings/0001193125-26-125205.md) | [11.4](/filings/0001193125-26-224062.md) | [11.7](/filings/0001193125-26-349234.md) | [11.5](/filings/0001193125-25-282989.md) | [10.8 d](/filings/0001193125-26-125205.md) | [10.6](/filings/0001193125-26-224062.md) | [11.0](/filings/0001193125-26-349234.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(6.6%)](/filings/0001193125-25-282989.md) | [(13.3%) d](/filings/0001193125-26-125205.md) | [(16.4%)](/filings/0001193125-26-224062.md) | [(4.6%)](/filings/0001193125-26-349234.md) | [(8.2%)](/filings/0001193125-25-282989.md) | [(21.9%) d](/filings/0001193125-26-125205.md) | [(12.7%)](/filings/0001193125-26-224062.md) | [(3.1%)](/filings/0001193125-26-349234.md) | | Net margin | % | [(6.6%)](/filings/0001193125-25-282989.md) | [(16.0%) d](/filings/0001193125-26-125205.md) | [(17.4%)](/filings/0001193125-26-349234.md) | [0.7%](/filings/0001193125-26-349234.md) | [(8.9%)](/filings/0001193125-25-282989.md) | [(21.4%) d](/filings/0001193125-26-125205.md) | [(16.2%)](/filings/0001193125-26-349234.md) | [(3.7%)](/filings/0001193125-26-349234.md) | | Diluted EPS | $ per share | [(0.02)](/filings/0001193125-25-282989.md) | not reported | [(0.05)](/filings/0001193125-26-224062.md) | [0.00](/filings/0001193125-26-349234.md) | [(0.02)](/filings/0001193125-25-282989.md) | not reported | [(0.04)](/filings/0001193125-26-224062.md) | [(0.01)](/filings/0001193125-26-349234.md) | | Free cash flow | $m | [0.2 d](/filings/0001193125-25-282989.md) | [0.8 d](/filings/0001193125-26-125205.md) | not reported | not reported | [0.3 d](/filings/0001193125-25-282989.md) | [0.1 d](/filings/0001193125-26-125205.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [53.5](/filings/0001564590-23-005061.md) | [52.2](/filings/0000950170-24-038807.md) | [49.9](/filings/0000950170-25-039513.md) | [48.1](/filings/0001193125-26-125205.md) | [45.4](/filings/0001193125-26-125205.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(22.1%)](/filings/0001564590-23-005061.md) | [(15.6%)](/filings/0000950170-24-038807.md) | [(19.3%)](/filings/0000950170-25-039513.md) | [(9.2%)](/filings/0001193125-26-125205.md) | [(12.6%)](/filings/0001193125-26-125205.md) | | Net margin | % | [(8.2%)](/filings/0001564590-23-005061.md) | [(15.8%)](/filings/0000950170-24-038807.md) | [(19.9%)](/filings/0000950170-25-039513.md) | [(10.3%)](/filings/0001193125-26-125205.md) | [(11.5%)](/filings/0001193125-26-125205.md) | | Diluted EPS | $ per share | [(0.10)](/filings/0001564590-23-005061.md) | [(0.19)](/filings/0001564590-23-005061.md) | [(0.23)](/filings/0000950170-25-039513.md) | [(0.11)](/filings/0001193125-26-125205.md) | [(0.12)](/filings/0001193125-26-125205.md) | | Free cash flow | $m | [(7.7)](/filings/0001564590-23-005061.md) | [(5.2)](/filings/0000950170-24-038807.md) | [(5.8)](/filings/0000950170-25-039513.md) | [(1.5)](/filings/0001193125-26-125205.md) | [(1.4)](/filings/0001193125-26-125205.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mchx/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Edenbrook Capital, LLC](/funds/1666682.md) | 2026-06-30 | $23.6m | 14,664,380 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $2.5m | 1,576,464 | | Reduced −29,440 | | [Kanen Wealth Management LLC](/funds/1681614.md) | 2026-06-30 | $2.2m | 1,300,388 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.7m | 1,079,881 | | Reduced −1,455 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.1m | 656,221 | | Added +16,226 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $645.2k | 400,627 | | Reduced −4,179 | | [P.A.W. CAPITAL CORP](/funds/949853.md) | 2026-06-30 | $644.0k | 400,000 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $327.8k | 203,633 | | Added +1,455 | | [Arax Advisory Partners](/funds/1586767.md) | 2026-06-30 | $234.9k | 145,908 | | New +145,908 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $226.5k | 140,696 | | Unchanged | ## Recent filings [All 1,089 filings](/companies/mchx/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-13 | 16:15 ET | [10-Q](/filings/0001193125-26-349234.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349234 | | 2026-08-12 | 16:20 ET | [8-K](/filings/0001193125-26-346915.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-346915 | | 2026-07-07 | 17:21 ET | [SCHEDULE 13D](/filings/0001193125-26-297650.md) | Ownership report, active investor | 0001193125-26-297650 | | 2026-07-01 | 16:15 ET | [8-K](/filings/0001193125-26-292561.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-292561 | | 2026-05-14 | 16:15 ET | [10-Q](/filings/0001193125-26-224062.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224062 | | 2026-05-13 | 16:20 ET | [8-K](/filings/0001193125-26-221701.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-221701 | | 2026-05-12 | 16:15 ET | [8-K](/filings/0001193125-26-219472.md) | 1.01 Entry into a material agreement | 0001193125-26-219472 | | 2026-05-01 | 16:15 ET | [8-K](/filings/0001193125-26-201467.md) | 1.01 Entry into a material agreement; 2.06 Material impairments | 0001193125-26-201467 | | 2026-04-17 | 16:15 ET | [10-K/A](/filings/0001193125-26-161560.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-161560 | | 2026-04-15 | 16:15 ET | [8-K](/filings/0001193125-26-157030.md) | 1.01 Entry into a material agreement | 0001193125-26-157030 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-125205.md), filed Mar 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/12ab8e1c-1135-4ec6-937a-a386449d6378) ## About the filer - CIK: 1224133 - Tickers: MCHX - Exchange: Nasdaq - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.